-
Heliyon Jul 2023Antimicrobial photodynamic therapy is emerging as a promising way to treat infections with minimal side effects. Typically, a single photosensitizer used in photodynamic...
Antimicrobial photodynamic therapy is emerging as a promising way to treat infections with minimal side effects. Typically, a single photosensitizer used in photodynamic therapy is capable of generating only one type of reactive oxygen species, which may have inadequate capability to eradicate certain types of microbes, especially species. Thus, the use of combined photosensitizers is examined as a means of achieving superior antimicrobial results. We postulate that bisdemethoxycurcumin, a type I reactive oxygen species generator, combined with potassium iodide, an antimicrobial iodide molecule, might exhibit superior antimicrobial effects compared to a single photosensitizer-mediated photodynamic therapy. The effects of bisdemethoxycurcumin + potassium iodide + dental blue light on reduction were examined. biofilms were treated with 20, 40 or 80 μM bisdemethoxycurcumin, 100 mM potassium iodide or a combination of these species for 20 min before irradiation with a dental blue light (90 J/cm). The negative and positive controls were phosphate buffer saline and nystatin at 1 : 100,000 units/ml, respectively. Candidal numbers were quantified at 0, 1, 6 and 24 h. Hydroxyl radicals were spectrophotometrically measured using 2-[6-(4'amino phynoxyl-3H-xanthen-3-on-9-yl)] benzoic acid or APF probe-mediated fluorescence intensity (Varioskan) at 490/515 nm (excitation/emission). Candidal counts and hydroxyl radical comparisons were performed using the Kruskal-Wallis test and one-way ANOVA, respectively. Correlations between candidal numbers and hydroxyl radical levels were done with a Pearson correlation test. Forty μM bisdemethoxycurcumin+100 mM KI could provide a 3.5 log CFU/ml reduction after 6 h. Bisdemethoxycurcumin alone generated OH levels that were strongly correlated with candidal reduction. In conclusion, 40 μM bisdemethoxycurcumin+100 mM KI could reduce biofilm.
PubMed: 37455953
DOI: 10.1016/j.heliyon.2023.e17490 -
Ultrasonics Sonochemistry Dec 2023Due to the complex physical and chemical interactions taking place in the sonicated medium, various methods have been proposed in the literature for a better...
Due to the complex physical and chemical interactions taking place in the sonicated medium, various methods have been proposed in the literature for a better understanding of the sonochemical system. In the present paper, the performance of calorimetry, iodometry, Fricke, 4-nitrophenol, HO, and ascorbic acid dosimetry techniques have been evaluated over the electric power range from 20 to 80 W (f = 300 kHz). These methods have been analyzed for distilled and seawater in light of the literature findings. It has been found that the lowest temperatures and calorimetric energies were obtained for seawater in comparison to distilled water. However, the discrepancy between both mediums disappears with the increase in the electric power up to 80 W. Compared to the calorimetry results, a similar trend was obtained for the KI dosimetry, where the discrepancy between both solutions (seawater and distilled water) increased with the reduction in the electric power down to 20 W. In contrast, over the whole range of the electric power (20-80 W), the HO dosimetry was drastically influenced by the salt composition of seawater, where, I formation was clearly reduced in comparison to the case of the distilled water. On the other hand, a fluctuated behavior was observed for the Fricke and 4-nitrophenol dosimetry methods, especially at the low electric powers (20 and 40 W). It has been found that dosimetry techniques based on ascorbic acid or potassium iodide are the best means for accurate quantification of the sonochemical activity in the irradiated liquid. As a result, it has been concluded, in terms of the dosimetry process's performance, that the dosimetry methods are in the following order: Ascorbic acid ≈ KI > Fricke > 4-nitrophenol > HO.
PubMed: 37944338
DOI: 10.1016/j.ultsonch.2023.106647 -
Nano Letters Sep 2023The rapid proliferative biological behavior of primary foci of anaplastic thyroid cancer (ATC) makes it a lethal tumor. According to the specific iodine uptake capacity...
The rapid proliferative biological behavior of primary foci of anaplastic thyroid cancer (ATC) makes it a lethal tumor. According to the specific iodine uptake capacity of thyroid cells and enhanced endocytosis of ATC cells, we designed a kind of nanoclay drug-loading system and showed a promising treatment strategy for ATC. Introducing potassium iodide (KI) improves the homoaggregation of clay nanoparticles and then affects the distribution of nanoparticles in vivo, which makes KI@DOX-Kaolin enriched almost exclusively in thyroid tissue. Simultaneously, the improvement of dispersibility of KI@DOX-Kaolin changes the target uptake of ATC cells by improving the endocytosis and nanoparticle-induced autophagy, which regulate the production of autolysosomes and autophagy-enhanced chemotherapy, eventually contributing to a tumor inhibition rate of more than 90% in the primary foci of ATC. Therefore, this facile strategy to improve the homoaggregation of nanoclay by introducing KI has the potential to become an advanced drug delivery vehicle in ATC treatment.
Topics: Humans; Thyroid Carcinoma, Anaplastic; Potassium Iodide; Kaolin; Endocytosis; Drug Delivery Systems; Thyroid Neoplasms
PubMed: 37615624
DOI: 10.1021/acs.nanolett.3c01984 -
Saudi Pharmaceutical Journal : SPJ :... Nov 2023Potassium iodide (KI) is a treatment to neutralize radioactive agents that could be inhaled or ingested in nuclear incidents. The inorganic salt KI constitutes a source...
OBJECTIVES
Potassium iodide (KI) is a treatment to neutralize radioactive agents that could be inhaled or ingested in nuclear incidents. The inorganic salt KI constitutes a source of iodine, which in the body acts by accumulating in the thyroid gland, producing its saturation, and thus preventing the fixation of radioactive iodine species. In Spain, the Military Defence Pharmacy Centre (CEMILFARDEF) was challenged to develop this antidote to be distributed among the population surrounding nuclear power plants, in only one new solid pharmaceutical form for oral administration, in order to replace the two pharmaceutical forms available, which are capsules for adults and oral solution for children, considered less versatile.
METHODS
A selection of excipients was carried out to achieve pharmacotechnical behaviour suitable for the industrial manufacture of potassium iodide in tablets, complying with the pre-established process and finished product quality parameters. The development allowed the preparation of three industrial-sized batches on which the stability of the developed formulation was studied.
RESULTS
An uncoated 65 mg double-scored potassium iodide tablet was developed using easily accessible excipients in the formulation and direct compression as the manufacturing method. The formula complied with the stability tests, with which the development carried out can respond to the eventual demand that its elaboration would entail in the event of nuclear incidents.
CONCLUSIONS
The developed formulation of a 65 mg double-scored potassium iodide tablet allows the great variability of user needs, from infants to adults with a single pharmaceutical form, which additionally implies logistical benefits in distribution, stock control and appropriate renewal according expiration dates, among the population surrounding nuclear power plants and available to deployed military personnel, in the event of potential nuclear incidents.
PubMed: 37868644
DOI: 10.1016/j.jsps.2023.101814